Last 12 months
Inside the activity.
1 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2018 Filed Aug 13, 2018 20:43 UTC |
Mattessich Antony C.Director · President and CEO
|
PurchaseCommon Stock | 16,900 | $6.23 | $105,287.00 |
DisclosureSEC source: 0001104659-18-051518 · a4.xml · nonDerivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,900 Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 17:23 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001104659-18-040493 · a4.xml · derivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 17:23 UTC |
PEACOCK BRUCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001104659-18-040496 · a4.xml · derivative · entry 1 PEACOCK BRUCE · CIK 0001228459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 17:23 UTC |
OSHEA WILLIAM JDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001104659-18-040494 · a4.xml · derivative · entry 1 OSHEA WILLIAM J · CIK 0001251725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 17:23 UTC |
Warden Charles MDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001104659-18-040495 · a4.xml · derivative · entry 1 Warden Charles M · CIK 0001354802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 21:23 UTC |
Heier Jeffrey S.Director
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001104659-18-040497 · a4.xml · derivative · entry 1 Heier Jeffrey S. · CIK 0001653082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 21:23 UTC |
Chadha JaswinderDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001104659-18-040492 · a4.xml · derivative · entry 1 Chadha Jaswinder · CIK 0001614407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:17 UTC |
Hanley Kevin F.Senior V.P.,Tech Operations
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001104659-18-007273 · a4.xml · derivative · entry 1 Hanley Kevin F. · CIK 0001727629 · Senior V.P.,Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-02-04 F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:34 UTC |
Mattessich Antony C.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 360,000 | $0.00 Strike: $5.47 | $0.00 |
DisclosureSEC source: 0001104659-18-006258 · a4.xml · derivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2028-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:36 UTC |
Goldstein Michael H.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 83,500 | $0.00 Strike: $5.47 | $0.00 |
DisclosureSEC source: 0001104659-18-006263 · a4.xml · derivative · entry 1 Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,500 Underlying: Common Stock · 83,500 shares Expires 2028-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:35 UTC |
Bollag Daniel MSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 51,100 | $0.00 Strike: $5.47 | $0.00 |
DisclosureSEC source: 0001104659-18-006262 · a4.xml · derivative · entry 1 Bollag Daniel M · CIK 0001461612 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,100 Underlying: Common Stock · 51,100 shares Expires 2028-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:34 UTC |
Notman DonaldChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 83,500 | $0.00 Strike: $5.47 | $0.00 |
DisclosureSEC source: 0001104659-18-006261 · a4.xml · derivative · entry 1 Notman Donald · CIK 0001718019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,500 Underlying: Common Stock · 83,500 shares Expires 2028-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:33 UTC |
Sawhney AmarpreetDirector · Exec Chairman of the Board
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $5.47 | $0.00 |
DisclosureSEC source: 0001104659-18-006256 · a4.xml · derivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:37 UTC |
Sawhney AmarpreetDirector · Exec Chairman of the Board · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 106,382 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001104659-17-074880 · a4.xml · derivative · entry 9 Sawhney Amarpreet · CIK 0001614417 · Director · Exec Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,382 shares Expires 2018-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted on January 31, 2013, and vested over four years with (i) approximately 25.2% of the shares underlying the option vesting on February 1, 2014, (ii) approximately 3.7% vesting monthly from January 1, 2015 to July 1, 2015, (iii) approximately 3.5% vesting on August 1, 2015, (iv) approximately 3.7% vesting monthly from January 1, 2016 to October 1, 2016, (v) approximately 0.8% vesting on November 1, 2016, and (vi) approximately 3.7% vesting monthly from January 1, 2017 to February 1, 2017. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:37 UTC |
Sawhney AmarpreetDirector · Exec Chairman of the Board · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 83,011 | $0.00 Strike: $2.49 | $0.00 |
DisclosureSEC source: 0001104659-17-074880 · a4.xml · derivative · entry 8 Sawhney Amarpreet · CIK 0001614417 · Director · Exec Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,011 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted on January 31, 2013, and vested over four years with (i) approximately 24.7% of the shares underlying the option vesting on February 1, 2014, (ii) approximately 4.8% vesting monthly from March 1, 2014 to December 1, 2014, (iii) approximately 0.3% vesting on August 1, 2015, (iv) approximately 4.8% vesting monthly from September 1, 2015 to December 1, 2015, (v) approximately 3.7% vesting on November 1, 2016, and (vi) approximately 4.8% vesting on December 1, 2016. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:37 UTC |
Sawhney AmarpreetDirector · Exec Chairman of the Board · 10% owner
|
Exercise / conversionCommon Stock | 106,382 | $2.73 | $290,422.86 |
DisclosureSEC source: 0001104659-17-074880 · a4.xml · nonDerivative · entry 2 Sawhney Amarpreet · CIK 0001614417 · Director · Exec Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 885,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:37 UTC |
Sawhney AmarpreetDirector · Exec Chairman of the Board · 10% owner
|
Exercise / conversionCommon Stock | 83,011 | $2.49 | $206,697.39 |
DisclosureSEC source: 0001104659-17-074880 · a4.xml · nonDerivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director · Exec Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 22:15 UTC |
Mattessich Antony C.Director · President and C.E.O.
|
PurchaseCommon Stock | 21,000 | $4.29 | $90,090.00 |
DisclosureSEC source: 0001104659-17-073177 · a4.xml · nonDerivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director · President and C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:27 UTC |
Notman DonaldChief Financial Officer
|
PurchaseCommon Stock | 4,800 | $4.00 | $19,200.00 |
DisclosureSEC source: 0001104659-17-072536 · a4.xml · nonDerivative · entry 1 Notman Donald · CIK 0001718019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $4.00, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 16:26 UTC |
Bollag Daniel MSee Remarks
|
PurchaseCommon Stock | 24,700 | $3.93 | $97,071.00 |
DisclosureSEC source: 0001104659-17-072535 · a4.xml · nonDerivative · entry 1 Bollag Daniel M · CIK 0001461612 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,700 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.89 to $4.03, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 13:04 UTC |
Sawhney AmarpreetDirector · Exec. Chairman of the Board · 10% owner
|
PurchaseCommon Stock | 19,000 | $5.18 | $98,420.00 |
DisclosureSEC source: 0001104659-17-069533 · a4.xml · nonDerivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director · Exec. Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 696,390 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.13 to $5.19, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 17:24 UTC |
Goldstein Michael H.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001104659-17-060662 · a4.xml · derivative · entry 1 Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2027-10-01 F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of Goldstein's first date of employment and 2.0833% of the shares vesting monthly thereafter. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 21:22 UTC |
Notman DonaldChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001104659-17-060659 · a4.xml · derivative · entry 1 Notman Donald · CIK 0001718019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-10-01 F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 18:02 UTC |
Bollag Daniel MSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001104659-17-050339 · a4.xml · derivative · entry 1 Bollag Daniel M · CIK 0001461612 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2027-08-06 F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and 2.0833% of the shares vesting monthly thereafter. Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 20:44 UTC |
Mattessich Antony C.Director
|
GrantStock Option (Right to Buy) · Derivative | 590,000 | $0.00 Strike: $10.94 | $0.00 |
DisclosureSEC source: 0001104659-17-040955 · a4.xml · derivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,000 Underlying: Common Stock · 590,000 shares Expires 2027-06-19 F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and 2.0833% of the shares vesting monthly thereafter. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001104659-17-037007 · a4.xml · derivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:29 UTC |
PEACOCK BRUCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001104659-17-037010 · a4.xml · derivative · entry 1 PEACOCK BRUCE · CIK 0001228459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:31 UTC |
GARVEY JAMES MDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001104659-17-037015 · a4.xml · derivative · entry 1 GARVEY JAMES M · CIK 0001207314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:29 UTC |
OSHEA WILLIAM JDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001104659-17-037009 · a4.xml · derivative · entry 1 OSHEA WILLIAM J · CIK 0001251725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:30 UTC |
Warden Charles MDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001104659-17-037013 · a4.xml · derivative · entry 1 Warden Charles M · CIK 0001354802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 22:31 UTC |
Chadha JaswinderDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001104659-17-037014 · a4.xml · derivative · entry 1 Chadha Jaswinder · CIK 0001614407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 22:27 UTC |
Heier Jeffrey S.Director
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001104659-17-037006 · a4.xml · derivative · entry 1 Heier Jeffrey S. · CIK 0001653082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| January 31, 2017 Filed Feb 10, 2017 16:36 UTC |
Hurley Charles AndrewChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0000899243-17-003497 · doc4.xml · derivative · entry 1 Hurley Charles Andrew · CIK 0001687394 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2017 Filed Feb 10, 2017 16:39 UTC |
Talamo Jonathan H.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0000899243-17-003500 · doc4.xml · derivative · entry 1 Talamo Jonathan H. · CIK 0001678995 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2017 Filed Feb 10, 2017 21:29 UTC |
Smith W BradfordCFO and Treasurer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0000899243-17-003482 · doc4.xml · derivative · entry 1 Smith W Bradford · CIK 0001317678 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2017 Filed Feb 10, 2017 21:35 UTC |
Fortune JamesChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0000899243-17-003494 · doc4.xml · derivative · entry 1 Fortune James · CIK 0001614458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2017 Filed Feb 10, 2017 21:38 UTC |
Ankerud EricSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0000899243-17-003499 · doc4.xml · derivative · entry 1 Ankerud Eric · CIK 0001614495 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 31, 2017 Filed Feb 10, 2017 21:34 UTC |
Sawhney AmarpreetDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 235,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0000899243-17-003490 · doc4.xml · derivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 235,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 21:04 UTC |
Sawhney AmarpreetDirector · President and CEO · 10% owner
|
PurchaseCommon Stock | 45,300 | $7.85 | $355,605.00 |
DisclosureSEC source: 0000899243-16-035752 · doc4.xml · nonDerivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,390 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.39 to $8.04, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 16:15 UTC |
Hurley Charles AndrewChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0000899243-16-032929 · doc4.xml · derivative · entry 1 Hurley Charles Andrew · CIK 0001687394 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2026-11-06 F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and 2.0833% of the shares vesting monthly thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.